Skip to main content

Home/ Cerebral Palsy/ Group items matching "inhibitor" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) - 0 views

www.clinicaltrials.gov/...NCT00992589

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease protein pump inhibitor reflux GERD study Rabeprazole PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Lee Vander Loop

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants - 0 views

www.clinicaltrials.gov/...NCT00888017

gastroesophageal reflux protein pump inhibitor gastroesophageal reflux disease antacids and neonates antacid contradiction in neonates clinical trial clinical trials reflux GERD antacids PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates
Lee Vander Loop

Effect of Selective COX-2 Inhibition on Ulcer Healing - 0 views

www.clinicaltrials.gov/...NCT00153673

clinical trial clinical trials Famotidine and ulcers study ulcer ulcers COX-2 inhibitor celecoxib

shared by Lee Vander Loop on 14 May 10 - Cached
  • Lee Vander Loop on 14 May 10
     
    Chinese Uversity of Hong Kong study comparing the effect of Famotidine plus a COX-2 inhibitor (celecoxib) with Famotidine plus dologesics in ulcer healing in arthritis patients."
Lee Vander Loop

The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease - 0 views

www.clinicaltrials.gov/...NCT01039558

clinical trial clinical trials gastroesophageal reflux Lansoprazole+Ecabet for treatment of GERD proton pump inhibitors GERD Lansoprazole Ecabet reflux

shared by Lee Vander Loop on 14 May 10 - Cached
  • Lee Vander Loop on 14 May 10
     
    Study to determine responses of lansoprazole and ecabet sodium combination therapy and compare with lansoprazole and placebo therapy in patients who need additional therapy after standard proton pump inhibitor treatment for 4week or more in recurrent gastroesophageal reflux disease.
Lee Vander Loop

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment - Full Text View - ClinicalTrials.gov - 0 views

www.clinicaltrials.gov/...NCT01103804

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease study GERD reflux

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Objective of the study is to describe the change in GerdQ sum scores, after a 4-week period of systematic treatment with PPIs(using GerdQ questionnaire). The secondary objectives are: to measure the response at the current treatment after a 4-week period of systematic treatment and to identify the percentage of patients which require alterations of their treatment (GerdQ questionnaire)"
1 - 5 of 5
Showing 20▼ items per page